Inder Verma

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Inder Verma
Born (1947-11-28) November 28, 1947 (age 70)
Sangrur, Punjab, India
Alma mater Lucknow University
Massachusetts Institute of Technology
Weizmann Institute of Science
Known for Cancer, gene therapy, NF-kB
Scientific career
Fields Molecular Biology
Institutions Salk Institute for Biological Studies

Inder Mohan Verma (born November 28, 1947) is an American Cancer Society Professor of Molecular Biology in the Laboratory of Genetics at the Salk Institute for Biological Studies [1] and the University of California, San Diego.[2] He is recognized for seminal discoveries in the fields of cancer, immunology, and gene therapy.

Verma was the editor-in-chief of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) from 2011 to 2017, but stepped down after being named in a gender discrimination lawsuit against the Salk Institute.[3] He is also the Jury Chair for the Infosys Prize 2013 for the discipline of Life Sciences.

Early life and education[edit]

Inder M. Verma was born in 1947 in Sangrur, Punjab, India and educated at Lucknow University. He received his Ph.D. from the Weizmann Institute of Science in Israel in 1971 and conducted his postdoctoral research in the laboratory of Nobel laureate David Baltimore at MIT.


In 1974, Verma joined the Salk Institute as an Assistant Professor. He was promoted to Associate Professor in 1979, and Professor in 1985. He also holds an Adjunct Professor appointment at the University of California, San Diego. Among his professional activities, he is a member of the Board of Scientific Governors of The Scripps Research Institute. He is currently at the center of a lawsuit alleging systematic discrimination against women scientists at the Salk Institute.[4]


Verma is one of the foremost recognized leaders in gene therapy, retrovirology, and cancer. His work on viruses and cancer led to the identification of several oncogenes, including c-fos, and their function in normal cells. His development of virus mediated gene transfer techniques, including a stripped down version of HIV, has become the foundation for gene therapy to cure several congenital as well as adult onset diseases including cancer. The viral vectors are routinely used in molecular biology laboratories.

Personal life[edit]

He married Grietje van der Woude in 1973. They have a daughter Simone, who lives in La Jolla. They have twin granddaughters, Sophie and Marijke.

Awards and honors[edit]


  1. ^ "Salk Institute Faculty Directory". Retrieved 25 November 2012. 
  2. ^ "UCSD Biology Faculty Directory". Retrieved 25 November 2012. 
  3. ^ Robbins, Gary (December 28, 2017), "Renowned Salk Institute scientist loses a top post due to gender discrimination claims", Los Angeles Times 
  4. ^ "Science". Retrieved 14 July 2017. 
  5. ^ "ASGCT press release". Retrieved 25 November 2012. 
  6. ^ "Vilcek Foundation press release". Retrieved 25 November 2012. 
  7. ^ "APS member directory". Retrieved 25 November 2012. 
  8. ^ "Book of Members, 1780–2010: Chapter V" (PDF). American Academy of Arts and Sciences. Retrieved 25 November 2012. 
  9. ^ "IOM member directory". Archived from the original on 10 December 2012. Retrieved 25 November 2012.